Metraipolis › archive › dc_9f416cd4c375

Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines — Europe PMC PMID:41441688

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41441688
DOI
10.3390/vaccines13121222
License (as archived)
solo-consultazione
Archived
2026-11-07T23:28:39.917Z
SHA-256 of the archived text
d4c5b6dd76c0a8762d07b78be8d9a38871f5f802d4850281c86fdeb9a410a6cb
Stable URL of this page
https://metraipolis.com/documento/dc_9f416cd4c375

How to cite

Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines — Europe PMC PMID:41441688 — Europe PMC (en), https://europepmc.org/article/MED/41441688 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9f416cd4c375 (Metraipolis archive dc_9f416cd4c375, sha256 d4c5b6dd76c0a8762d07b78be8d9a38871f5f802d4850281c86fdeb9a410a6cb)
BibTeX
@misc{dc9f416cd4c375,
  title = {Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines — Europe PMC PMID:41441688},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41441688},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9f416cd4c375; sha256 d4c5b6dd76c0a8762d07b78be8d9a38871f5f802d4850281c86fdeb9a410a6cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41441688. Agents can read the archived copy with the MCP tool read_document.